ArticleTropical animal health and production2026
Injectable trace minerals (Cu, Mn, Se, Zn) as immunometabolic modulators in the treatment of tropical theileriosis in neonatal calves.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tropical theileriosis, a lymphoproliferative disease caused by Theileria annulata, remains a major threat to bovine health and productivity, particularly in tropical and subtropical regions. This study aimed to evaluate the comparative therapeutic efficacy of buparvaquone alone and in combination with long-acting oxytetracycline and injectable trace minerals (ITMs) in neonatal calves naturally infected with T. annulata. Forty-three infected crossbred calves aged 7–90 days were enrolled and randomly assigned to four treatment groups. Hematological and biochemical parameters were evaluated pre- and post-treatment (day 0 and day 14) to assess clinical recovery. Among enrolled calves, 30 completed the study. All treatment regimens resulted in significant hematological and metabolic improvements; however, the combination therapy of buparvaquone, oxytetracycline, and ITMs demonstrated the most profound recovery, with marked increases in erythrogram indices (TEC ↑93.0%, Hb ↑98.0%, HCT ↑63.4%) and substantial normalization of hepatic enzymes (ALT ↓62.4%, AST ↓62.8%, LDH ↓48.4%). This group also showed improved immune cell profiles, including monocytes (↑171.4%) and lymphocytes (↑25.3%), indicating enhanced immune reconstitution. The results underscore the potential of integrative therapeutic strategies combining antiprotozoals with antimicrobial and trace minerals support to enhance recovery in neonatal theileriosis. These findings advocate for the inclusion of injectable trace minerals supplementation as an adjunct in the therapeutic management of theileriosis to improve hematologic, hepatic, and immunologic outcomes.
Indexed as
Identifiers
41543798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.